Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
NIPA1 encodes a magnesium transporter that associates with early endosomes and the cell surface in a variety of neuronal and epithelial cells. Additionally we are shipping NIPA1 Kits (4) and and many more products for this protein.
Showing 5 out of 5 products:
we employed an shRNA-encoding lentivirus system to inhibit SPG6 expression in AML (show RUNX1 Antibodies) cells including NB4 and MV4-11cells. Knockdown expression of SPG6 resulted in decreased cell growth and elevated apoptosis of these leukemia cells. Notably, SPG6 deficiency resulted in higher BMPR2 (show BMPR2 Antibodies) expression indicating that BMPR2 (show BMPR2 Antibodies) signaling contributes to AML (show RUNX1 Antibodies) pathogenesis.
This study showed that the mutations of were detected in SPG11 (show SPG11 Antibodies), ATL1 (show ATL1 Antibodies), NIPA1, and ABCD1 (show ABCD1 Antibodies) in patient with hereditary spastic paraplegia.
NIPA1 repeat expansion in the context of a C9orf72 (show C9ORF72 Antibodies) repeat expansion would drive toward a motor neuron disease phenotype.
We report here a family with a pure form of Hereditary spastic paraplegia due to a de novo transition mutation in the NIPA1 gene.
study reports direct evidence of de novo c.316G>A mutation in the same hotspot of the gene in two unrelated patients who had otherwise a prototypical NIPA1-associated phenotype with a severe form of uncomplicated spastic paraplegia
NIPA1 polyalanine repeat expansions are a common risk factor for ALS and modulate disease course
Epilepsy might be more common in spastic paraplegia type 6 than in other forms of Hereditary spastic paraplegia because of a genetic risk factor closely linked to NIPA1.
One heterozygous missense mutation of NIPA1 was identified in a complicated form of hereditary spastic paraplegia type 6 family with peripheral nerves disease
a genome-wide association study of amyotrophic lateral sclerosis identified the NIPA1 locus as a candidate for more in-depth studies
discovery of a dominant negative mutation in the NIPA1 gene in a kindred with autosomal dominant hereditary spastic paraplegia
This gene encodes a magnesium transporter that associates with early endosomes and the cell surface in a variety of neuronal and epithelial cells. This protein may play a role in nervous system development and maintenance. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene have been associated with autosomal dominant spastic paraplegia 6.
magnesium transporter NIPA1
, non-imprinted in Prader-Willi/Angelman syndrome 1
, non-imprinted in Prader-Willi/Angelman syndrome region protein 1
, spastic paraplegia 6 protein
, non-imprinted in Prader-Willi/Angelman syndrome region protein 1 homolog
, spastic paraplegia 6 homolog